Condition: Acute Aortic Dissection · Thoracic Aortic Aneurysm · Sponsor: University Hospital, Basel, Switzerland
The aim of this study is to explore the genetic information associated with the development of TAA and aAD in individuals without history or syndromic features (Marfan syndrome, Ehlers-Danlos syndrome, Turner syndrome etc.) for aortic disease. For this purpose, whole genome sequencing will be performed in patients with documented aortic aneurysm or/and aortic dissection.
This description comes directly from the study's public registry record.
Denis Berdajs, Prof. Dr. · 0041 61 328 71 80 · denis.berdajs@usb.ch
Islam Salikhanov, Dr. · 0041 61 26 53225 · Islam.Salikhanov@usb.ch
Always discuss trial participation with your own doctor first.
| University Hospital Basel | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06353607